National Hospitalization Trends for Pediatric Pneumonia and Associated Complications

被引:141
作者
Lee, Grace E. [1 ,2 ,4 ]
Lorch, Scott A. [3 ,4 ,5 ,6 ]
Sheffler-Collins, Seth [1 ]
Kronman, Matthew P. [1 ,6 ]
Shah, Samir S. [1 ,2 ,4 ,5 ,6 ]
机构
[1] Childrens Hosp Philadelphia, Div Infect Dis, Philadelphia, PA 19104 USA
[2] Childrens Hosp Philadelphia, Div Gen Pediat, Philadelphia, PA 19104 USA
[3] Childrens Hosp Philadelphia, Div Neonatol, Philadelphia, PA 19104 USA
[4] Univ Penn, Sch Med, Dept Pediat, Philadelphia, PA 19104 USA
[5] Univ Penn, Sch Med, Dept Biostat & Epidemiol, Philadelphia, PA 19104 USA
[6] Univ Penn, Sch Med, Ctr Clin Epidemiol & Biostat, Philadelphia, PA 19104 USA
基金
美国国家卫生研究院;
关键词
pneumonia; pleural empyema; epidemiology; heptavalent pneumococcal conjugate vaccine; PNEUMOCOCCAL CONJUGATE VACCINE; COMMUNITY-ACQUIRED PNEUMONIA; STREPTOCOCCUS-PNEUMONIAE; YOUNG-CHILDREN; CHANGING EPIDEMIOLOGY; PARAPNEUMONIC EMPYEMA; EMERGENCY-DEPARTMENT; OCCULT BACTEREMIA; UNITED-STATES; DISEASE;
D O I
10.1542/peds.2009-3109
中图分类号
R72 [儿科学];
学科分类号
100202 ;
摘要
OBJECTIVE: To determine current rates of and trends in hospitalizations for community-acquired pneumonia (CAP) and CAP-associated complications among children. METHODS: We performed a cross-sectional, retrospective, cohort study by using the 1997, 2000, 2003, and 2006 Kids' Inpatient Database. National estimates for CAP and CAP-associated local and systemic complication rates were calculated for children <= 18 years of age. Patients with comorbid conditions or in-hospital birth status were excluded. Percentage changes were calculated by using 1997 (before heptavalent pneumococcal conjugate vaccine [PCV7]) and 2006 (after PCV7) data. RESULTS: There were a total of 619 102 CAP discharges for 1997, 2000, 2003, and 2006, after application of inclusion and exclusion criteria. Overall rates of CAP discharges did not change substantially between 1997 and 2006, but stratification according to age revealed a 22% decrease for children <1 year of age, minimal change for children 1 to 5 years of age, and increases for children 6 to 12 years (22%) and >= 13 years (41%) of age. Systemic complication rates were highest among children <1 year of age but decreased by 36%. In all other age groups, systemic complication rates remained stable. Local complication rates increased 78% overall. Children 1 to 5 years of age had the highest local complication rates. CONCLUSIONS: After the introduction of PCV7 in 2000, rates of CAP-associated systemic complications decreased only for children <1 year of age. Rates of pediatric CAP-associated local complications are increasing in all age groups. Pediatrics 2010;126:204-213
引用
收藏
页码:204 / 213
页数:10
相关论文
共 45 条
  • [1] Changing characteristics of invasive pneumococcal disease in metropolitan Atlanta, Georgia, after introduction of a 7-valent pneumococcal conjugate vaccine
    Albrich, W. C.
    Baughman, W.
    Schmotzer, B.
    Farley, M. M.
    [J]. CLINICAL INFECTIOUS DISEASES, 2007, 44 (12) : 1569 - 1576
  • [2] [Anonymous], 2000, MMWR Recomm Rep, V49, P1
  • [3] Postlicensure surveillance for pneumococcal invasive disease after use of heptavalent pneumococcal conjugate vaccine in Northern California Kaiser Permanente
    Black, S
    Shinefield, H
    Baxter, R
    Austrian, R
    Bracken, L
    Hansen, J
    Lewis, E
    Fireman, B
    [J]. PEDIATRIC INFECTIOUS DISEASE JOURNAL, 2004, 23 (06) : 485 - 489
  • [4] Effectiveness of heptavalent pneumococcal conjugate vaccine in children younger than five years of age for prevention of pneumonia
    Black, SB
    Shinefield, HR
    Ling, S
    Hansen, J
    Fireman, B
    Spring, D
    Noyes, J
    Lewis, E
    Ray, P
    Lee, J
    Hackell, J
    [J]. PEDIATRIC INFECTIOUS DISEASE JOURNAL, 2002, 21 (09) : 810 - 815
  • [5] Surveillance for invasive pneumococcal disease during 2000-2005 in a population of children who received 7-valent pneumnococcal conjugate vaccine
    Black, Steven
    France, Eric K.
    Isaacman, Daniel
    Bracken, Laura
    Lewis, Edwin
    Hansen, John
    Fireman, Bruce
    Austrian, Robert
    Graepel, Jay
    Gray, Sharon
    Klein, Nicola P.
    [J]. PEDIATRIC INFECTIOUS DISEASE JOURNAL, 2007, 26 (09) : 771 - 777
  • [6] Incidence and etiologies of complicated parapneumonic effusions in children, 1996 to 2001
    Buckingham, SC
    King, MD
    Miller, ML
    [J]. PEDIATRIC INFECTIOUS DISEASE JOURNAL, 2003, 22 (06) : 499 - 504
  • [7] Impact of the pneumococcal conjugate vaccine on pneumococcal parapneumonic empyema
    Byington, CL
    Korgenski, K
    Daly, J
    Ampofo, K
    Pavia, A
    Mason, EO
    [J]. PEDIATRIC INFECTIOUS DISEASE JOURNAL, 2006, 25 (03) : 250 - 254
  • [8] *CDCP, 1990, NAT CTR HLTH STAT BR
  • [9] *CDCP, NAT IMM SURV CHILDR
  • [10] Clinical features, aetiology and outcome of empyema in children in the north east of England
    Eastham, KM
    Freeman, R
    Kearns, AM
    Eltringham, G
    Clark, J
    Leeming, J
    Spencer, DA
    [J]. THORAX, 2004, 59 (06) : 522 - 525